Last reviewed · How we verify
NCT03122158
Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
Phase 4 trial testing Escitalopram in Major Depressive Disorder in 60 participants. Status unknown.
15 September 2018
Quick facts
| Lead sponsor | Erzurum Regional Training & Research Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 8 April 2017 |
| Primary completion | 15 September 2018 |
| Estimated completion | 15 December 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Escitalopram (escitalopram) — full drug profile →
Conditions studied
- Major Depressive Disorder — all drugs for Major Depressive Disorder →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
Erzurum Regional Training & Research Hospital
Who can join
Adults 12 to 18, any sex, with Major Depressive Disorder or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Escitalopram has been approved by FDA in the treatment of adolescents with major depressive disorder since March 2009. To date, there are only 3 clinical trials assessing the effect and validity of escitalopram on major depressive disorder, which of them has resulted in inconsistent findings. In the present study, the authors aimed to assess the effect and validity of this drug in the treatment of adolescents with major depressive disorder and or anxiety disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03122158
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Escitalopram
Trials testing the same drug.
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT07331987 — Efficacy and Safety of Probiotics for Anxiety Depression · NA · not yet recruiting
- NCT06216535 — Escitalopram in Asthma Patients With Frequent Exacerbation · Phase 2 · recruiting
- NCT06937476 — Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole · NA · active not recruiting
- NCT05603104 — Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First- · Phase 3 · recruiting
Other recruiting trials for Major Depressive Disorder
Currently open trials in the same condition.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting
Other Erzurum Regional Training & Research Hospital trials
Trials by the same sponsor.
- NCT05117307 — Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section · NA · not yet recruiting
- NCT07079033 — Can We Reliably Needle Hip Muscles Blindly? · NA · not yet recruiting
- NCT07074249 — Blind Needling Accuracy in Lumbar Muscles · NA · not yet recruiting
- NCT07311096 — Interscalene Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery · NA · completed
- NCT07311902 — M-Tapa Block and Transversus Abdominal Plane Block for Postoperative Analgesia in Unilateral Open Inguinal Hernia Repair · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03122158 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Erzurum Regional Training & Research Hospital
- Last refreshed: 20 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03122158.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing